Ulcerative Colitis Summary

Networked: 11289 relevant articles (1290 outcomes, 1612 trials/studies) for this Disease

Key Drugs and Agents for Ulcerative Colitis

1. Mesalamine (Mesalazine) : 242 outcomes 143 studies in 766 results : FDA 10 Generic
   
2. infliximab (Remicade) : 128 outcomes 103 studies in 574 results : FDA 2
   
3. Sulfasalazine (Azulfidine) : 88 outcomes 60 studies in 392 results : FDA 16 Generic
   
4. Cyclosporine (Ciclosporin) : 69 outcomes 39 studies in 276 results : FDA 20 Generic
   
5. Azathioprine (Imuran) : 64 outcomes 29 studies in 243 results : FDA 7 Generic
   
6. Adrenal Cortex Hormones (Corticosteroids) : 60 outcomes 24 studies in 278 results : IBA
   
7. Steroids : 38 outcomes 21 studies in 201 results : IBA
   
8. adalimumab (Humira) : 35 outcomes 24 studies in 124 results : FDA 2
   
9. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 30 outcomes 28 studies in 258 results : IBA
   
10. 6-Mercaptopurine (Mercaptopurine) : 28 outcomes 11 studies in 88 results : FDA 4 Generic
    

Diseases Related to Ulcerative Colitis

1. Crohn Disease (Crohn's Disease)
2. Colitis
3. Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
4. Inflammation
5. Proctitis

Key Therapies for Ulcerative Colitis

1. Enema (Enemas) : 82 outcomes 84 studies in 343 results
   
2. Colectomy : 54 outcomes 89 studies in 1027 results
   
3. Blood Component Removal (Apheresis) : 32 outcomes 13 studies in 109 results
   
4. Remission Induction : 25 outcomes 21 studies in 68 results
   
5. Restorative Proctocolectomy : 20 outcomes 52 studies in 521 results